医学
膜性肾病
肾病综合征
美罗华
内科学
蛋白尿
环磷酰胺
胃肠病学
肿瘤科
淋巴瘤
肾
化疗
作者
Soumita Bagchi,Vineet Behera,Sanjay Kumar Agarwal
标识
DOI:10.1016/j.kint.2019.04.018
摘要
Primary membranous nephropathy is a common cause of nephrotic syndrome in adults. Failure to achieve remission of proteinuria is a risk factor for progression to end-stage renal disease. 1 Couser W.G. Primary membranous nephropathy. Clin J Am Soc Nephrol. 2017; 12: 983-997 Crossref PubMed Scopus (288) Google Scholar Cyclophosphamide with steroids, calcineurin inhibitors, and rituximab have been used for treating primary membranous nephropathy with response rates varying from 50% to 70%. 1 Couser W.G. Primary membranous nephropathy. Clin J Am Soc Nephrol. 2017; 12: 983-997 Crossref PubMed Scopus (288) Google Scholar It is difficult to predict response, and some patients who do not improve with one immmunosuppressive regimen may respond to another therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI